(Q44341273)

2 December 2017

title

Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens (English)

1 reference

2 December 2017

0 references

1 reference

N Kabli

1

1 reference

2 December 2017

T Nguyen

2

1 reference

2 December 2017

G Balboni

3

1 reference

2 December 2017

B F O'Dowd

4

1 reference

2 December 2017

S R George

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

24 September 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

19

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

986-994

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2013.115

2 December 2017

exact match

0 references

cites work

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Association of beta-endorphin with specific clinical symptoms of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Regulation of Human Affective Responses by Anterior Cingulate and Limbic µ-Opioid Neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Buprenorphine treatment of refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Possible antidepressive effects of opioids: action of buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The role of beta-endorphin in the pathophysiology of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of and Opioid Receptor Hetero-oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Delta opioid receptor ligands modulate anxiety-like behaviors in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The antidepressant -like effects of delta-opioid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Behavioral effects of delta-opioid receptor agonists: potential antidepressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Enkephalin and other peptides reduce passiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The delta opioid receptor: an evolving target for the treatment of brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Opioid receptor genes inactivated in mice: the highlights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Enhanced serotonin response in the hippocampus of Galphaz protein knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

In vivo protein transduction: delivery of a biologically active protein into the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Augmentation of fear extinction by infusion of glycine transporter blockers into the amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Nucleus accumbens long-term depression and the expression of behavioral sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Blockade of amygdala metabotropic glutamate receptor subtype 1 impairs fear extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Behavioural despair in rats: A new model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Antidepressant-like behavioral effects of serotonin receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Nucleus accumbens facilitates nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Dopamine neurons modulate neural encoding and expression of depression-related behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Effects of inhibitor of κB kinase activity in the nucleus accumbens on emotional behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.115

Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

21 January 2018

1 reference

12 December 2020

Antidepressant effects of buprenorphine

1 reference

12 December 2020

Increased abundance of opioid receptor heteromers after chronic morphine administration

1 reference

12 December 2020

Effects of co-administration of fluoxetine or tianeptine with metyrapone on immobility time and plasma corticosterone concentration in rats subjected to the forced swim test

1 reference

12 December 2020

Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with Met5-enkephalin.

1 reference

12 December 2020

mu-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens

1 reference

12 December 2020

Lack of ventral striatal response to positive stimuli in depressed versus normal subjects.

1 reference

12 December 2020

Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin

1 reference

12 December 2020

A possible role of opioid substances in depression.

1 reference

12 December 2020

Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens

1 reference

12 December 2020

Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.

1 reference

12 December 2020

Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.

1 reference

12 December 2020

Methadone and morphine in depression [proceedings]

1 reference

12 December 2020

Gamma-aminobutyric acid in the medial rat nucleus accumbens: ultrastructural localization in neurons receiving monosynaptic input from catecholaminergic afferents

1 reference

12 December 2020

The mesolimbic dopamine system as a target for rapid antidepressant action.

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2013.115

1 reference

Dimensions Publication ID

2 December 2017

1029992282

0 references

Fatcat ID

release_fxvfnn56ovduhl3kue3bhqvyla

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fxvfnn56ovduhl3kue3bhqvyla

24 November 2022

mapped directly with Wikidata item

1 reference